According to the latest research by InsightAce Analytic, the global Stereotactic Surgery Devices market will be valued at US$ 18.24 Billion in 2021. It is expected to grow with a CAGR of 5.5% during a forecast period of 2022-2030. Rising innovations and advancement in modern surgical procedures has led to the rise in demand for various non – invasive surgical devices such as Stereotactic Surgery Devices. Stereotactic surgery, also known as Stereotaxy, is a minimally invasive surgical technique that leverages three dimensional co-ordinates system to detect small targets inside the body and accordingly performs actions on it such as biopsy, lesion, ablation, stimulation, radiosurgery, injection, and implantation. Precision and high accuracy is the key characteristics of Stereotactic Surgery Devices. The engineering principles of arc centred stereotactic frames maximizes the accuracy of surgical procedures and ensures high precision.
Stereotactic surgery devices are composed of stereotactic frames, radiofrequency generator, and image-based planning software. With respect to degree of utility, the stereotactic frames in the stereotactic surgery devices are further classified into Simple orthogonal system, Burr hole mounted system, Arc quadrant system and Arc phantom system. With a help of 3D coordinate system, the stereotactic surgery device helps the surgeons in spotting the particular location to execute the surgical procedure. Continuous improvement in the surgical technologies has recorded with significant market acceptance. Thus existing demand and future growth in the market for non – invasive surgical procedures has resulted in increase in research and development activities in market for Stereotactic Surgery Devices. Rising acceptance and increasing demand for Stereotactic Surgery Devices 
leading to propel its market with significant CAGR during the forecast year of 2019 to 2030.
On the basis of equipment type, the global stereotactic surgery devices market can be further segmented into the gamma knife, line accelerator (LINAC) machines, CyberKnife and proton beam (particle beam). Line accelerator (LINAC) machines comprises the major segment for stereotactic surgery devices market, and it is anticipated to grow steadily over the forecasted period 2019 – 2030. Based on Application Type, the stereotactic surgery devices market can be further segmented into arteriovenous malformations treatment, brain tumor treatment, Parkinson’s disease, Epilepsy, and other neurological disorders including trigeminal neuralgia.
Geographically, the market for stereotactic surgery devices can be grouped into regions such as North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa. With significantly strong clinical and healthcare facilities, high market acceptance and increasing adoption rate of new technologies has led the markets such as U.S., Canada, and most of the European to major market share. Moreover, developing markets in Asia Pacific has also recorded significant growth in the market.
The key players operating in the global stereotactic surgery devices market includes Siemens AG, Elekta AB, Varian Medical Systems, IBA worldwide, Accuray Incorporated, Alliance Oncology, Micromar, Adeor Medical AG, Monteris Medical, and Inomed. Development and deployment of new innovative products with an enhanced clinical outcomes is the key strategy adopted by market players to sustain in a heavy industry competition. Market for stereotactic surgery devices is evolving dynamically due to increased research and development activities and consequently diverse product offerings to the customer. The market for stereotactic surgery devices also experience various organic and inorganic development activities resulting in a rise in improved product offerings.
